Skip to main content

ESSA Pharma Inc.

EPIXDelisted Oct 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001633932

ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding ESSA Pharma Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of EPIX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5445−9
Shares33.8M33.4M−425.4K (−1.3%)
Value$62.2M$84.1M+$21.9M (+35.3%)

New holders (8)

Institutions that held ESSA Pharma Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to EPIX in Q4 2022
InstitutionSharesValue% of portfolio
Ally Bridge Group (NY) LLC811,555$2.05M1.99%
Driehaus Capital Management LLC264,571$666.7K0.01%
Kapitalo Investimentos Ltda33,400$84.2K0.07%
Jump Financial, LLC27,500$69.3K0.00%
One Wealth Advisors, LLC8,333$21.0K0.00%
UBS Group AG6,522$16.4K0.00%
BNP Paribas Arbitrage, SA1,500$3.78K0.00%
Group One Trading, L.P.109$2750.00%

Sold out (17)

Institutions that held ESSA Pharma Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of EPIX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Eventide Asset Management, LLC1,561,251$2.84M
RTW Investments, LP1,311,294$2.39M
Candriam Luxembourg S.C.A.417,532$760.0K
MPM Oncology Impact Management LP405,700$738.0K
Woodline Partners LP382,282$696.0K
Omega Fund Management, LLC328,196$597.0K
Marshall Wace, LLP115,122$209.0K
Acadian Asset Management LLC72,046$129.0K
Price T Rowe Associates Inc44,832$82.0K
Raymond James & Associates40,619$74.0K
AlpInvest Partners B.V.39,930$73.0K
Goldman Sachs Group Inc24,531$45.0K
Alps Advisors Inc24,052$44.0K
XTX Topco Ltd23,338$42.0K
Susquehanna International Group, LLP19,872$36.0K
Alta Wealth Advisors LLC11,285$21.0K
Aquatic Capital Management LLC3,300$6.00K